LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Acquisition Opportunities Pardes Biosciences has recently been acquired by Medi Corp and Midpac, indicating potential shifts in strategic direction that could lead to new business opportunities for sales partnerships or collaborations.

Key Personnel Changes With the recent appointment of Thomas G. Wiggans as CEO and Chairman, there may be a reinvigoration of leadership and vision that sales teams could leverage to explore fresh market approaches and engagement strategies.

Emerging Product Development Pardes Biosciences is actively developing drug candidates such as PBI-0451 for COVID-19 treatment and prevention, presenting a prime opportunity for sales teams to align products or services that complement their innovative pipeline.

Market Positioning In a competitive landscape with companies like Rallybio, Generation Bio, and SQZ Biotechnologies, understanding where Pardes stands can help sales teams tailor their pitch and offerings to highlight unique selling points and value propositions.

Funding Strength With a funding of $75M, Pardes Biosciences has financial stability to support potential expansion or business growth initiatives, making them an attractive partner for sales collaborations or long-term engagements.

Similar companies to Pardes Biosciences

✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Pardes Biosciences Tech Stack

Pardes Biosciences uses 8 technology products and services including QuickBooks, WordPress, Font Awesome, and more. Explore Pardes Biosciences's tech stack below.

  • QuickBooks
    Accounting And Finance
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • RSS
    Miscellaneous
  • Acquia Cloud Platform
    Platform As A Service
  • BambooHR
    Recruitment Marketing
  • Akamai Bot Manager
    Security
  • OpenResty
    Web Servers

Media & News

Pardes Biosciences's Email Address Formats

Pardes Biosciences uses at least 1 format(s):
Pardes Biosciences Email FormatsExamplePercentage
First.Last@pardesbio.comJohn.Doe@pardesbio.com
51%
First@pardesbio.comJohn@pardesbio.com
30%
FLast@pardesbio.comJDoe@pardesbio.com
15%
FirstLast@pardesbio.comJohnDoe@pardesbio.com
4%

Frequently Asked Questions

Where is Pardes Biosciences's headquarters located?

Minus sign iconPlus sign iconPardes Biosciences's main headquarters is located at Carlsbad, CA US. The company has employees across 1 continents, including North America.

What is Pardes Biosciences's stock symbol?

Minus sign iconPlus sign iconPardes Biosciences is a publicly traded company; the company's stock symbol is PRDS.

What is Pardes Biosciences's official website and social media links?

Minus sign iconPlus sign iconPardes Biosciences's official website is pardesbio.com and has social profiles on LinkedIn.

What is Pardes Biosciences's SIC code NAICS code?

Minus sign iconPlus sign iconPardes Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pardes Biosciences have currently?

Minus sign iconPlus sign iconAs of July 2023, Pardes Biosciences has approximately 51 employees across 1 continents, including North America. Key team members include Chief Executive Officer: D. A.Chief Scientific Officer: L. A.Vice President Of Government Affairs: J. M.. Explore Pardes Biosciences's employee directory with LeadIQ.

What industry does Pardes Biosciences belong to?

Minus sign iconPlus sign iconPardes Biosciences operates in the Biotechnology Research industry.

What technology does Pardes Biosciences use?

Minus sign iconPlus sign iconPardes Biosciences's tech stack includes QuickBooksWordPressFont AwesomeRSSAcquia Cloud PlatformBambooHRAkamai Bot ManagerOpenResty.

What is Pardes Biosciences's email format?

Minus sign iconPlus sign iconPardes Biosciences's email format typically follows the pattern of . Find more Pardes Biosciences email formats with LeadIQ.

How much funding has Pardes Biosciences raised to date?

Minus sign iconPlus sign icon As of July 2023, Pardes Biosciences has raised $75M in funding. The last funding round occurred on Dec 27, 2021 for $75M.

When was Pardes Biosciences founded?

Minus sign iconPlus sign iconPardes Biosciences was founded in 2020.
Pardes Biosciences

Pardes Biosciences

Biotechnology ResearchCalifornia, United States51-200 Employees

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. By capitalizing on emerging patient-friendly innovations from telehealth to new at-home diagnostic tools, Pardes is cultivating and harvesting the fruits of systemic change. We are on a mission to stop a pandemic and start a movement so patients everywhere can get well sooner.

✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Carlsbad, CA US
Website
pardesbio.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRDS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    Pardes Biosciences has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Dec 27, 2021 in the amount of $75M.

Section iconFunding & Financials

  • $75M

    Pardes Biosciences has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Dec 27, 2021 in the amount of $75M.

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.